Mepharm (India) Private Limited - Company Profile

It is a business services private limited company based in New Delhi, Delhi, India, established in 1994.
1994 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Mepharm (India) Private Limited

Mepharm (India) Private Limited, a struck off private limited company, was established on 29 April 1994 in New Delhi, Delhi, India. it holds CIN: U74899DL1994PTC058713. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Vikas Rai (Director), Abhyuday Dugar (Additional Director), Aman Chawla (Additional Director). Past directors included Rachna Rai. Its latest AGM occurred on 29 August 2009, with the balance sheet filed on 31 March 2009. It is based at 29A/1 Asaf Ali Road, New Delhi, Delhi, 110002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1994PTC058713

  • Registration Number

    058713

  • Incorporation Date

    29 April 1994

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 31 Year, 10 Months
  • Last Filing with ROC 31 Mar 2009
Company report

Mepharm (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mepharm (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Mepharm (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Vikas Rai Director 17 Mar 2002 Current
Abhyuday Dugar Additional Director 24 Jul 2008 Current
Aman Chawla Additional Director 24 Jul 2008 Current
Suneel Anand Director 21 Nov 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 21 Nov 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mepharm (India).

Enhance accessibility to Mepharm (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Mepharm (India) revenue growth over time
Mepharm (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mepharm (India)?

Unlock access to Mepharm (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Mepharm (India)?

Unlock and access historical data on people associated with Mepharm (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mepharm (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mepharm (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mepharm (India)
Recent Activity within the Organization
  • Annual General Meeting

    The activity Mepharm (India) Private Limited last Annual general meeting of members was held on 29 Aug 2009 as per latest MCA records. was completed.

  • Balance Sheet

    Mepharm (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2009 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Suneel Anand was appointed as a Director was appointed as a Director on 21 Nov 2008 & has been associated with this company since 17 years 3 months . was documented.

  • Director Appointment

    The activity Abhyuday Dugar was appointed as a Additional Director was appointed as a Additional Director on 24 Jul 2008 & has been associated with this company since 17 years 7 months . was completed.

  • Director Appointment

    Aman Chawla was appointed as a Additional Director was appointed as a Additional Director on 24 Jul 2008 & has been associated with this company since 17 years 7 months . was recorded as a recent event.

  • Director Appointment

    The activity Vikas Rai was appointed as a Director was appointed as a Director on 17 Mar 2002 & has been associated with this company since 23 years 11 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mepharm (India) Private Limited?

The CIN of Mepharm (India) Private Limited is U74899DL1994PTC058713.

Where is Mepharm (India) Private Limited headquartered?

Mepharm (India) Private Limited is headquartered at 29A/1 Asaf Ali Road, New Delhi, Delhi, 110002.

When was Mepharm (India) Private Limited incorporated?

Mepharm (India) Private Limited was incorporated on 29 April 1994.

Who are the current directors of Mepharm (India) Private Limited?

The current directors of Mepharm (India) Private Limited are

Is Mepharm (India) Private Limited a listed company?

Mepharm (India) Private Limited is unlisted.

What is the capital structure of Mepharm (India) Private Limited?

The authorized capital of Mepharm (India) Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available